Next Article in Journal
Integrative Approach to Risk Factors in Simple Chronic Obstructive Airway Diseases of the Lung or Associated with Metabolic Syndrome—Analysis and Prediction
Next Article in Special Issue
Assessment of Vitamin D Status in the Drâa-Tafilalet Population (Morocco) Based on Sociodemographic, Health, and Nutritional Factors
Previous Article in Journal
Long-Term Fasting-Induced Ketosis in 1610 Subjects: Metabolic Regulation and Safety
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Based on Network Pharmacology and Molecular Docking, the Active Components, Targets, and Mechanisms of Flemingia philippinensis in Improving Inflammation Were Excavated

1
College of Science, Yunnan Agricultural University, Kunming 650201, China
2
College of Food and Biological Engineering, Hezhou University, Hezhou 542899, China
3
College of Food Science and Technology, Yunnan Agricultural University, Kunming 650201, China
4
Institute of Agricultural Products Processing, Yunnan Academy of Agricultural Sciences, Kunming 650201, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Nutrients 2024, 16(12), 1850; https://doi.org/10.3390/nu16121850
Submission received: 19 May 2024 / Revised: 5 June 2024 / Accepted: 11 June 2024 / Published: 13 June 2024

Abstract

:
Flemingia philippinensis, a polyphenol-rich plant, holds potential for improving inflammation, but its mechanisms are not well understood. Therefore, this study employed network pharmacology and molecular docking to explore the mechanism by which Flemingia philippinensis ameliorates inflammation. In this study, 29 kinds of active ingredients were obtained via data mining. Five main active components were screened out for improving inflammation, which were flemichin D, naringenin, chrysophanol, genistein and orobol. In total, 52 core targets were identified, including AKT serine/threonine kinase 1 (AKT1), tumor necrosis factor (TNF), B-cell lymphoma-2 (BCL2), serum albumin (ALB), and estrogen receptor 1 (ESR1). Gene ontology (GO) enrichment analysis identified 2331 entries related to biological processes, 98 entries associated with cellular components, and 203 entries linked to molecular functions. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis yielded 149 pathways, including those involved in EGFR tyrosine kinase inhibitor resistance, endocrine resistance, and the PI3K–Akt signaling pathway. Molecular docking results showed strong binding effects between the main active components and the core targets, with binding energies less than −5 kcal/mol. In summary, this study preliminarily elucidated the underlying mechanisms by which Flemingia philippinensis, through a multi-component, multi-target, and multi-pathway approach, ameliorates inflammation. This provides a theoretical foundation for the subsequent application of Flemingia philippinensis in inflammation amelioration.

1. Introduction

With the rapid development of society, the research and treatment of inflammatory diseases face new challenges and opportunities. Inflammation is the protective response of organisms to tissue injury or infection, and it is the dynamic defense response of organisms to invading pathogens. This reaction involves a series of complex processes, including phagocytosis, the release of inflammatory cytokines and chemokines, which can help organisms destroy and eliminate pathogens [1]. However, excessive and persistent inflammation can cause irreversible damage to the organism itself, and even endanger life [2]. At the same time, inflammation plays an important role in the occurrence and development of many diseases. For example, the persistent occurrence of inflammatory reaction plays an important role in the process of cancer initiation, promotion, malignant transformation, invasion, and metastasis [3]. In addition, inflammation is also one of the main causes of heart disease, and chronic inflammation can induce an arterial injury process, such as atherosclerosis [4]. At present, some studies have regarded inflammatory regression as a new method to treat inflammatory diseases [5]. At present, the therapeutic effect of anti-inflammatory drugs has been fully confirmed. Dexamethasone, as a glucocorticoid, is mainly used to treat inflammatory diseases [6]. However, long-term use of such drugs usually leads to serious life-threatening side effects [7]. Therefore, it is particularly important to find products with excellent curative effects and little toxicity as anti-inflammatory drug components.
Phenolic metabolites in plants are one of the main sources of substances that ameliorate inflammation [8]. Polyphenols, also known as phenolic compounds, are a class of chemical substances containing aromatic rings and at least two hydroxyl groups. They are widely found in plants and have excellent pharmacological and nutritional properties, including antiviral, antioxidant, and anti-inflammatory activities [9]. Flemingia philippinensis (Merr. et Rolfe) is a Chinese herbal medicine rich in polyphenols, especially isoflavone derivatives. This Chinese herbal medicine is planted on a large scale, mainly distributed in Yunnan, Guizhou, Guangxi, and Sichuan, and widely eaten by local residents as an important nutritional health product [10]. As a traditional medicinal and edible plant, Flemingia philippinensis from the Philippines has been widely applied in the treatment of various diseases, including chronic nephritis and rheumatoid arthritis. Additionally, it has demonstrated potential therapeutic effects in alleviating pain and improving certain gynecological conditions [11,12,13]. Existing research has indicated that the flavonoids in Flemingia philippinensis extract not only have anti-inflammatory effects, but also have a variety of biological activities such as anti-thrombosis, anti-oxidation, liver protection, and cardiovascular diseases [14]. The presence of these compounds provides a broad basis for the pharmacological action of Flemingia philippinensis, making it a potential natural drug resource for the treatment of a variety of diseases. In addition, the study of the chemical composition of the Flemingia philippinensis has shown that in addition to flavonoids, it also contains coumarin, saponins, volatile oils, and other compounds [15]. The diversity of these compounds further enhances the medicinal value of Flemingia philippinensis, and makes it have potential application prospects in the treatment of different diseases.
Although it has been reported that Flemingia philippinensis extract has the effect of improving inflammation, at present, the active ingredients, targets, and mechanisms of improving inflammation are still unclear [16]. However, the integration of bioinformatics and network pharmacology provides a practical method for exploring its mechanism of action [17]. Network pharmacology is a new subject developed based on systems biology, pharmacology, and modern computer technology, which can systematically reveal the active components in drugs and predict the relationship between drug components and gene targets [18,19]. Molecular docking can verify the interaction between active compounds and central therapeutic target [20]. Therefore, based on the research idea of the drug–target pathway, this study obtained the active ingredients and their targets for improving inflammation through multi-platform databases, and used Venny 2.1.0 and Cytoscape 3.9.1 software to construct the topological network of the active ingredient improving inflammation. Network pharmacological analysis technology and molecular docking technology were used to explore the active ingredients, targets, and mechanisms of Flemingia philippinensis in improving inflammation, in order to provide a theoretical basis for the effect of Flemingia philippinensis in improving inflammation.

2. Materials and Methods

Firstly, the main active components were searched in the traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP), the China National Knowledge Infrastructure (CNKI), and the PubMed database, and then combined with a search in the Swiss Target Prediction database, the action targets of each active component were predicted. We obtained zetargets related to inflammation through the Disease Gene Network (DisGENET) and GeneCards databases; Venny 2.1.0 and Cytoscape 3.9.1 were used to construct the Flemingia philippinensis–active ingredients–anti-inflammation target network, and the main active components of Flemingia philippinensis were screened according to their node degree values. A protein–protein interaction (PPI) network was constructed by the String database, and the key targets of improving inflammation were screened by node degree value. The David database was used for gene ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. Finally, AutoDock 4.2.6 software was used to perform molecular docking between the main active ingredients and the key targets for improving inflammation (Figure 1).

2.1. Searching for the Active Ingredients of Flemingia philippinensis

The active ingredients of Flemingia philippinensis were searched through the TCMSP (https://test.tcmsp-e.com/tcmsp.php, accessed on 2 February 2024), CNKI (https://www.cnki.net/, accessed on 2 February 2024), and PubMed (https://pubmed.ncbi.nlm.nih.gov/, accessed on 2 February 2024) databases. Firstly, using TCMSP database, we set “Herb Name” as “Flemingia philippinensis” to search and export its active ingredients; secondly, CNKI database and PubMed data were used to search for the active ingredients related to Flemingia philippinensis. The repetitive active ingredient obtained via the above steps was removed, that is, the active ingredient of Flemingia philippinensis was obtained. We then downloaded the Smile format of these active ingredients from the PubChem (https://pubchem.ncbi.nlm.nih.gov/, accessed on 10 February 2024) database at the time of active ingredient screening, and then from the Swiss ADME (http://www.swissadme.ch/index.php, accessed on 10 February 2024) database, according to the values of ADME screening of the active ingredient. According to Lipinski, Ghose, Veber, Egan, and Muegge, there are at least three ways to dig out the active ingredients of Flemingia philippinensis.

2.2. Target Prediction for the Active Ingredients of Flemingia philippinensis

The Swiss Target Prediction (http://swisstargetprediction.ch/, accessed on 15 February 2024) database is an online tool for predicting drug targets. It utilizes known compounds with 2D and 3D structure similarity for forecasting compound treatment targets [21]. In the present study, we downloaded the SMILES formats of the active ingredients in Flemingia philippinensis from the PubChem database, imported them into the Swiss Target Prediction database, and set the species as “Homo sapiens”. The predictions of the potential targets of the active ingredients were obtained by using “Probability > 0.01” as the screening condition.

2.3. Screening for Potential Targets of the Anti-Inflammatory Effects of Flemingia philippinensis

Inflammation-associated targets were obtained from the DisGeNET (https://www.disgenet.org/, accessed on 16 February 2024) and GeneCards (https://www.genecards.org/, accessed on 16 February 2024) databases. “Inflammation” was input into the search box of the DisGeNET database and the GeneCards database to retrieve the related targets. Subsequently, the targets associated with inflammation were obtained, and after deduplication and summarization, the relevant targets were identified. In Section 2.2, the Swiss Target Prediction database was utilized to predict that the active ingredients of Flemingia philippinensis potentially target a broad spectrum of diseases. Therefore, with further help from the Venny 2.1.0 (https://bioinfogp.cnb.csic.es/tools/venny/, accessed on 16 February 2024) platform, we screened the intersection of inflammation-related targets with the target of action of the active ingredient of Flemingia philippinensis, so as to obtain the potential targets of Flemingia philippinensis for ameliorating inflammation.

2.4. Analysis of Protein Interaction Network and Screening for Key Targets

The potential targets screened by Section 2.3 were visually analyzed through the String (https://cn.string-db.org/, accessed on 20 February 2024) database. The selected biological species was homo sapiens to obtain the PPI. The obtained PPI network data information was also analyzed with the help of Cytoscape 3.9.1, and topological methods were further used to filter out the core targets in the PPI network graphs based on degree centrality (DC), betweenness centrality (BC), and closeness centrality (CC) [22].

2.5. Construction of the Network Diagram of Flemingia philippinensis–Active Ingredients–Targets for Improving Inflammation

The data obtained in Section 2.2 and Section 2.4 were imported into Cytoscape 3.9.1 software, and the network diagram of Flemingia philippinensis–active ingredients–targets for improving inflammation was constructed. The larger the node degree value, the darker the node color.

2.6. GO Enrichment Analysis and KEGG Pathway Analysis

Through the David (https://david.ncifcrf.gov/, accessed on 25 February 2024) database, GO function analysis and KEGG pathway enrichment analysis were carried out on the potential targets of active ingredients in improving inflammation. The top 10 p-values of biological process (BP), molecular function (MF), and cellular component (CC) in the GO analysis were selected for further analysis, including the creation of bar charts and chord charts. Subsequently, the top 20 pathways based on p-values were chosen for KEGG pathway enrichment analysis, along with the generation of Sankey bubble diagrams and chord diagrams. Correlations between these pathways were then evaluated. The results of these analyses shed light on the potential mechanisms underlying the anti-inflammatory effects of the active ingredients.

2.7. Molecular Docking Analysis

Molecular docking technology can intuitively show the degree of binding between the active components and the target [23]. In order to further verify the interaction between the selected active compounds and the core targets, the top 5 active compounds and the core targets were selected for molecular docking based on the degree values. In this study, AutoDock 4.2.6 was utilized to conduct molecular docking of the main active ingredients, including Flemichin D (CAS: 57096-07-8), Naringenin (CAS: 480-41-1), Chrysophanol (CAS: 481-74-3), genistein (CAS: 446-72-0), and Orobol (CAS: 480-23-9), with the key targets AKT serine/threonine kinase 1 (AKT1) (PDB ID: 7NH5), tumor necrosis factor (TNF) (PDB ID: 2AZ5), B-cell lymphoma-2 (BCL2) (PDB ID: 6GL8), serum albumin (ALB) (PDB ID: 6R7S), and estrogen receptor 1 (ESR1) (PDB ID: 1L2I). First, the main active ingredient was downloaded from the PubChem database (https://pubchem.ncbi.nlm.nih.gov/, accessed on 5 March 2024) in SDF format and with a 3D structure. It was then imported into Chem3D 20.0 for energy and structure optimization, setting the minimum RMS gradient to 0.001. Ligand preprocessing was conducted using AutoDock 4.2.6, which involved the addition of all hydrogens and the designation of the ligand. After inspecting the rotatable bonds, the ligand was exported as a pdbqt file for subsequent molecular docking calculations [24]. After that, the protein structure of the key target was downloaded from the PDB database (https://www.rcsb.org/, accessed on 5 March 2024) and imported into PyMOL 2.5 to remove excess ligands. Then, the structure of the key protein molecule was pretreated with AutoDock 4.2.6, including dehydration and hydrogenation, and used as the receptor. Selected as the receptor, it was then exported as a pdbqt file for subsequent molecular docking calculations [25]. To identify the binding site of the receptor, DoGSiteScorer (https://proteins.plus/, accessed on 5 March 2024) developed by the Bioinformatics Centre at Universität Hamburg was utilized for the online prediction of binding pockets [26]. Finally, AutoDock 4.2.6 was used to perform molecular docking and calculate binding energy, and Discovery Studio 2021 was used to produce graphs.

3. Results

3.1. Active Ingredients of Flemingia philippinensis

The traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP), China National Knowledge Infrastructure (CNKI), and PubMed databases were used to search for the active ingredients of Flemingia philippinensis. After collecting and removing the repeated values and invalid ingredients, 29 active ingredients in total were obtained [16,27,28,29,30,31] (Table 1).

3.2. Prediction of the Potential Targets for Anti-Inflammatory Improvement by Flemingia philippinensis

An initial search in the Disease Gene Network (DisGeNET) and GeneCards databases identified 4458 inflammation-related targets. All the targets of Flemingia philippinensis were predicted by the Swiss Target Prediction database, and 462 were obtained. Potential targets of Flemingia philippinensis for ameliorating inflammation were screened using Venny 2.1.0, and 320 in total were obtained (Figure 2).

3.3. Protein Interaction Analysis

Using the STRING database, protein interaction analysis was carried out on 320 intersection targets for improving inflammation from Flemingia Philippinensis, and a protein–protein interaction (PPI) network was constructed (Figure 3A). In total, 319 nodes and 5264 connecting lines between nodes were obtained. In order to further screen the core target proteins in the PPI network, this study used Cytoscape 3.9.1 to analyze the topology of PPI network nodes, and selected the target values that were greater than those of degree centrality (DC), betweenness centrality (BC), and closeness centrality (CC). In total, 52 core targets including protein AKT serine/threonine kinase 1 (AKT1), serum albumin (ALB), B-cell lymphoma-2 (BCL2), tumor necrosis factor (TNF), and estrogen receptor 1 (ESR1) were obtained (Figure 3B, Table 2).

3.4. Network of Flemingia philippinensis–Active Ingredients–Their Targets for Inflammation Improvement

The Flemingia philippinensis–active ingredient–inflammatory core targets network shows that (Figure 4), in addition to Flemingia philippinensis, five ingredients, Flemichin D, Naringenin, Chrysophanol, Genistein, and Orobol, had the darkest nodes, suggesting that they are the main active components of Flemingia philippinensis in improving inflammation. In addition, each target node was connected by multiple edges, indicating that the anti-inflammatory effects of Flemingia philippinensis result from the synergistic actions of various compounds.

3.5. GO Enrichment Analysis of Potential Inflammatory Targets in Flemingia philippinensis

In total, 2632 items were involved in the gene ontology (GO) enrichment analysis of potential targets for improving inflammation. The top 10 items in each section were ranked from the lowest to highest p-value (Figure 5). The biological processes included 2331 biological processes such as peptidyl-serine phosphorylation, peptidyl-serine modification, peptidyl-tyrosine phosphorylation, etc. Cell composition included 98 components such as membrane rafts, membrane microdomains, membrane regions, etc. Molecular functions included 203 functions such as nuclear receptor activity, ligand-activated transcription factor activity, protein tyrosine kinase activity, etc. (p < 0.01).

3.6. KEGG Pathway Enrichment Analysis of the Potential Anti-Inflammatory Targets of Flemingia philippinensis

In total, 149 related pathways were obtained via Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. (p < 0.01). According to the p-value, the top 20 pathways were sorted, and a Sankey bubble plot was created (Figure 6). The results showed that the targets of Flemingia philippinensis in improving inflammation were mainly involved in EGFR tyrosine kinase inhibitor resistance, prostate cancer, and endocrine resistance. Additionally, the PI3K–Akt signaling pathway and the HIF-1 signaling pathway play important roles in improving inflammation. Among the core targets identified, 12 are involved in resistance to EGFR tyrosine kinase inhibitor resistance, 15 are associated with prostate cancer, 14 are implicated in endocrine resistance, 17 are engaged in the PI3K–Akt signaling pathway, and 10 are involved in the HIF-1 signaling pathway. Among them, the PI3K–Akt pathway, with the most core targets, may be the most important pathway in which Flemingia philippinensis improves inflammation (Figure 7). In addition, multiple core targets were found to be involved in multiple pathways simultaneously. When Flemingia philippinensis regulates a specific pathway, changes in target expression may have chain or indirect effects on other pathways. The results showed that Flemingia philippinensis could improve inflammation by regulating multiple targets and related pathways, and there were high correlations among different pathways.

3.7. Analysis of Molecular Docking

The top five core target proteins identified, AKT1, TNF, BCL2, ALB, and ESR1, were subjected to molecular docking analysis with the top five principal active components known for their anti-inflammatory properties, namely Flemichin D, Naringenin, Chrysophanol, Genistein, and Orobol. The results showed that the binding energies between the main active ingredients and the core target proteins were all less than -5 kcal/mol, indicating that the predicted active ingredients had good binding properties with the key targets. (Table 3 and Figure 8). Among them, the binding energy of Flemichin D to the core target protein was lower than that of the other components, indicating that Flemichin D plays an important role in improving inflammation in Flemingia philippinensis.

4. Discussion

Inflammatory processes are known to play a key role in a variety of psychosomatic pathologies, including ischemic heart disease, diabetes, neurodegenerative diseases, depression, and schizophrenia [32]. Most of these diseases are considered to be chronic inflammatory diseases and exhibit high morbidity and mortality worldwide [33]. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of non-glucocorticoid medications widely used to ameliorate inflammation [34]. Although they can provide temporary relief of inflammatory responses, their long-term therapeutic efficacy is limited and cannot cure the disease. Additionally, prolonged use of NSAIDs may lead to gastrointestinal, hepatic, and renal damage, as well as adverse effects on the hematopoietic system and the central nervous system [35]. Plant resources show great potential in the improvement of inflammatory conditions. Numerous plants are rich in natural anti-inflammatory constituents, such as polyphenols, flavonoids, and terpenes. These components significantly alleviate inflammatory responses by inhibiting the release of inflammatory mediators, reducing oxidative stress, and modulating immune responses [36,37,38]. Although the anti-inflammatory effects of Flemingia philippinensis have been reported, the underlying mechanisms remain unclear. To further explore the bioactive role of Flemingia philippinensis in improving inflammation, this study, for the first time, systematically investigated the mechanisms by which the active components of Flemingia philippinensis improve anti-inflammatory effects using a combination of network pharmacology and molecular docking methods. The results showed that Flemingia philippinensis had a multi-component and multi-target effect, and different active ingredients exerted their anti-inflammatory effect.
Topological network analysis showed that the nodes of Flemichin D, Naringenin, Chrysophanol, Genistein, and Orobol were the largest, indicating that these five components are the main active components of Flemingia philippinensis in improving inflammation. The PPI network analysis revealed strong interaction effects between the active components of Flemingia philippinensis and their target proteins. According to the degree values, AKT serine/threonine kinase 1 (AKT1), tumor necrosis factor (TNF), B-cell lymphoma-2 (BCL2), serum albumin (ALB), and estrogen receptor 1 (ESR1) are the top five key targets. Molecular docking results demonstrated that the top five active ingredients could spontaneously bind to the top five target proteins, with Flemichin D being the most significant in improving inflammation. Flemichin D is the major flavonoid in Flemingia philippinensis. However, it has not been reported that it can improve inflammation [31]. Related studies have shown that Flemiphilippinin D, a compound similar to Flemichin D, can reduce the secretion of pro-inflammatory factors and reduce the inflammatory response through TLR2/MyD88/NF-κB signaling pathway, thus playing an anti-rheumatic effect [39]. This suggests that Flemichin D is also a potential inflammation-ameliorating compound. Naringenin is a flavonoid widely present in plants with antioxidant, anti-inflammatory, and immunomodulatory effects [40,41]. It has shown promising preventive and therapeutic effects in experimental models of chronic inflammatory and autoimmune diseases [42]. Chrysophanol, a major component of plant extracts used in many traditional Chinese medicines (TCMs), has shown diabetes-improving, anti-inflammatory, anti-cancer, neuroprotective, and liver-protecting effects [43]. Genistein is a kind of isoflavone mainly extracted from soybean, which has anti-inflammatory, antioxidant, and anti-cancer effects [44]. Orobol, a derivative of genistein, has the ability to improve acne inflammation caused by Propionibacterium acnes [45].
Gene ontology (GO) analysis showed that Flemingia philippinensis could improve inflammation through peptidyl-serine phosphorylation, peptidyl-serine modification, peptidyl-tyrosine phosphorylation, the response to the molecule of bacterial origin, and other biological processes. Phosphorylation is a widespread type of post-translational modification. More than 30% of proteins in cells can be phosphorylated to regulate intracellular signal transduction and metabolic processes. Therefore, phosphorylation is the most basic, universal, and important mechanism that regulates and controls protein activity and function [46]. Studies have shown that phosphorylation can regulate the activation of the inflammasome by targeting different inflammatory components, including NLRP3, NLRC4, IFI16, ASC, and Caspase-1. A large number of phosphorylation events can regulate the initiation, self-assembly, localization, and degradation of NLRP3 inflammatory cells [47]. Analysis of the cellular components revealed that the main targets of Flemingia philippinensis in improving inflammation are the membrane raft, membrane microdomain, membrane region, and apical part of the cell. Membrane microregions are relatively stable microregions on the membrane that are rich in specific proteins and lipids (including cholesterol, glycosphingolipids, sphingolipids, lipid rafts, and membrane caveolae). Related studies have found that cytokine stimulation during inflammation can induce Fcγ receptor I to accumulate in membrane microregions, thereby promoting the binding of immune complexes to monomeric IgG [48]. Molecular functions include nuclear receptor activity, ligand-activated transcription factor activity, protein tyrosine kinase activity, and serine/threonine protein kinase activity. Serine/threonine protein kinases have been shown to alleviate inflammation by phosphorylating serine and threonine residues on proteins. Receptor-interacting serine/threonine protein kinase 1(RIPK1) is a cytosolic protein kinase that can ameliorate inflammation [49].
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that the effect of Flemingia philippinensis on inflammation was mainly involved in EGFR tyrosine kinase inhibitor resistance, the PI3K–AKT signaling pathway, and the HIF-1 signaling pathway. EGFR is the receptor for epithelial growth factor (EGF) cell proliferation and signal transduction. PI3K–AKT is a classical intracellular signaling pathway, which is involved in the regulation of many physiological and pathological processes. Among these three inflammation-related pathways, the PI3K–Akt signaling pathway has the largest number of genes and thus may be a key pathway to improving inflammation. Relevant studies have shown that activating EGFR can activate the PI3K–AKT signaling pathway [50]. Activation of the PI3K–AKT signaling pathway plays a key role in acute and chronic inflammation [51,52]. At the same time, the PI3K–AKT signaling pathway can be involved in the regulation of multiple biological processes, such as cell proliferation, apoptosis, and glucose metabolism [53]. In addition, activated AKT can promote the expression and secretion of proinflammatory cytokines by activating the NF–κB pathway, leading to an imbalance of cytokine secretion and a series of inflammatory responses [54]. HIF-1 is a heterodimer composed of two subunits, Hif-1α and HIF-1β, whose transcriptional activity is triggered by hypoxia. It plays an important role in the development of the cardiovascular system, immune system, and cartilage [55]. Studies have found that activated HIF-1α can directly bind to the promoter of the TNF-α gene, thereby increasing the expression of TNF-α [56]. Therefore, the main mechanism by which Flemingia philippinensis ameliorated inflammation in this study may have included Flemingia philippinensis reducing cellular inflammation by regulating EGFR tyrosine kinase inhibitor resistance, the PI3K–AKT signaling pathway, and HIF-1 signaling pathway. These results indicated that multiple biological processes were involved in the anti-inflammatory effect of Flemingia philippinensis, and that the anti-inflammatory effect of Flemingia philippinensis was mediated by multiple components, targets, and pathways.
The results of this study provide strong theoretical support for improvements in inflammation to be achieved by Flemingia philippinensis. However, there are still some limitations in this study. Firstly, the information obtained from online databases is based on searched and predicted data; hence, unverified and undocumented compounds or targets may not be included in the analysis of this study. Secondly, the current research on the quantitative determination of the 29 compounds is not yet perfected; hence, future studies should focus on the quantification of these compounds. Thirdly, future research should investigate the effective components, absorption pathways, and metabolic forms of bioactive substances in Flemingia philippinensis. Fourthly, this study does not encompass polysaccharides, proteins, and other macromolecular compounds, which also require further investigation. Therefore, further research is required to explore the potential molecular mechanisms by which Flemingia philippinensis improves inflammation in vitro and in vivo.

5. Conclusions

In this study, network pharmacology and molecular docking methods were used to explore the mechanism by which Flemingia philippinensis ameliorated inflammation. The results showed that Flemingia philippinensis had the characteristics of multi-component, multi-target, and multi-pathway involvement in improving inflammation. However, while the results of this study, based on database analysis and network visualization, show the effect of key components on improving inflammation, they lack data on the effect of drug dosage. Therefore, these findings need further verification through cell and animal experiments in the future. However, the results of this study provide a theoretical basis for the development of multi-component, multi-target, and multi-pathway drugs for improving inflammation-related conditions. This study not only fills the research gap regarding the anti-inflammatory mechanisms of Flemingia philippinensis but also provides a reference method for the in-depth pharmacological study of other plants.

Author Contributions

D.Z.: validation, formal analysis, writing original draft, and supervision. Q.Z.: methodology, validation, investigation, and writing and editing original draft. Z.Z.: methodology, validation, investigation, and writing original draft. X.Y.: methodology, investigation, and writing original draft. J.M.: methodology, investigation, and writing original draft. D.W.: methodology, investigation, and writing original draft. X.L.: writing original draft, supervision, project administration, and funding acquisition. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by Guangxi key research and development project; project name: The technological innovation and application of Guangxi characteristic medicinal herbs Flemingia philippinensis in the whole industrial chain (GuikeAB22035077).

Data Availability Statement

The original contributions presented in this study are included in the article’s material. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  1. Hou, C.; Chen, L.; Yang, L.; Ji, X. An insight into anti-inflammatory effects of natural polysaccharides. Int. J. Biol. Macromol. 2020, 153, 248–255. [Google Scholar] [CrossRef] [PubMed]
  2. Zhang, Z.B.; Luo, D.D.; Xie, J.H.; Xian, Y.F.; Lai, Z.Q.; Liu, Y.H.; Liu, W.H.; Chen, J.N.; Lai, X.P.; Lin, Z.X.; et al. Curcumin’s Metabolites, Tetrahydrocurcumin and Octahydrocurcumin, Possess Superior Anti-inflammatory Effects in vivo Through Suppression of TAK1-NF-κB Pathway. Front. Pharmacol. 2018, 9, 1181. [Google Scholar] [CrossRef] [PubMed]
  3. Zhao, H.; Wu, L.; Yan, G.; Chen, Y.; Zhou, M.; Wu, Y.; Li, Y. Inflammation and tumor progression: Signaling pathways and targeted intervention. Signal Transduct. Target. Ther. 2021, 6, 263. [Google Scholar] [PubMed]
  4. Doran, A.C. Inflammation Resolution: Implications for Atherosclerosis. Circ. Res. 2022, 130, 130–148. [Google Scholar] [CrossRef] [PubMed]
  5. Gilroy, D.W.; Lawrence, T.; Perretti, M.; Rossi, A.G. Inflammatory resolution: New opportunities for drug discovery. Nat. Rev. Drug Discov. 2004, 3, 401–416. [Google Scholar] [CrossRef] [PubMed]
  6. Sun, L.; Wang, B.; Sun, T.; Zhou, F.; Zhu, B.; Li, C.; Wan, H.; Ding, Z. Investigation on the mechanism of 2,3,4′,5-Tetrahydroxystilbene 2-o-D-glucoside in the treatment of inflammation based on network pharmacology. Comput. Biol. Med. 2022, 145, 105448. [Google Scholar] [CrossRef] [PubMed]
  7. Polderman, J.A.; Farhang-Razi, V.; Van Dieren, S.; Kranke, P.; DeVries, J.H.; Hollmann, M.W.; Preckel, B.; Hermanides, J. Adverse side effects of dexamethasone in surgical patients. Cochrane Database Syst. Rev. 2018, 11, Cd011940. [Google Scholar] [PubMed]
  8. Cai, P.J.; Sun, A.D.; Jia, G.L. Research Progress on Anti-inflammatory Activity and Microencapsulation of Plant Polyphenols. J. Chin. Inst. Food Sci. Technol. 2022, 22, 417–427. [Google Scholar]
  9. Liu, W.; Cui, X.; Zhong, Y.; Ma, R.; Liu, B.; Xia, Y. Phenolic metabolites as therapeutic in inflammation and neoplasms: Molecular pathways explaining their efficacy. Pharmacol. Res. 2023, 193, 106812. [Google Scholar] [CrossRef] [PubMed]
  10. Kim, J.Y.; Wang, Y.; Li, Z.P.; Baiseitova, A.; Ban, Y.J.; Park, K.H. Xanthine Oxidase Inhibition and Anti-LDL Oxidation by Prenylated Isoflavones from Flemingia philippinensis Root. Molecules 2020, 25, 3074. [Google Scholar] [CrossRef] [PubMed]
  11. Ahn, E.M.; Nakamura, N.; Akao, T.; Nishihara, T.; Hattori, M. Estrogenic and antiestrogenic activities of the roots of Moghania philippinensis and their constituents. Biol. Pharm. Bull. 2004, 27, 548–553. [Google Scholar] [CrossRef]
  12. Li, L.; Deng, X.; Zhang, L.; Shu, P.; Qin, M. A new coumestan with immunosuppressive activities from Flemingia philippinensis. Fitoterapia 2011, 82, 615–619. [Google Scholar] [CrossRef] [PubMed]
  13. Li, H.; Yang, M.; Ma, X. Flavonoids from roots of Flemingia philippinensis. China J. Chin. Mater. Medica 2009, 34, 724–726. [Google Scholar]
  14. Yan, D.; Xia, B.H.; Li, C.; Liu, S.; Li, Y.M.; Liao, D.F.; Lin, L.M.; Wu, P. Research progress on medicinal plants of Flemingia Roxb. ex W. T. Ait. Chin. Tradit. Herb. Drugs 2016, 47, 4456–4471. [Google Scholar]
  15. Li, L.; Qin, M.J.; Zhang, L.X.; Zhao, Q. Advances in the Chemical Constituents and Biological Activities of Flemingia Plants. Mod. Pharm. Clin. 2009, 24, 203–211. [Google Scholar]
  16. Sun, G.; Xing, C.; Zeng, L.; Huang, Y.; Sun, X.; Liu, Y. Flemingia philippinensis Flavonoids Relieve Bone Erosion and Inflammatory Mediators in CIA Mice by Downregulating NF-κB and MAPK Pathways. Mediat. Inflamm. 2019, 2019, 5790291. [Google Scholar] [CrossRef]
  17. Jain, B.; Raj, U.; Varadwaj, P.K. Drug Target Interplay: A Network-based Analysis of Human Diseases and the Drug Targets. Curr. Top. Med. Chem. 2018, 18, 1053–1061. [Google Scholar] [CrossRef]
  18. Zhang, P.; Zhang, D.; Zhou, W.; Wang, L.; Wang, B.; Zhang, T.; Li, S. Network pharmacology: Towards the artificial intelligence-based precision traditional Chinese medicine. Brief. Bioinform. 2023, 25, bbad518. [Google Scholar] [CrossRef] [PubMed]
  19. Li, S.; Zhang, B. Traditional Chinese medicine network pharmacology: Theory, methodology and application. Chin. J. Nat. Med. 2013, 11, 110–120. [Google Scholar] [CrossRef]
  20. Yu, J.W.; Yuan, H.W.; Bao, L.D.; Si, L.G. Interaction between piperine and genes associated with sciatica and its mechanism based on molecular docking technology and network pharmacology. Mol. Divers. 2021, 25, 233–248. [Google Scholar] [CrossRef] [PubMed]
  21. Daina, A.; Michielin, O.; Zoete, V. SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019, 47, W357–W364. [Google Scholar] [CrossRef] [PubMed]
  22. Liu, J.; Shi, J.L.; Guo, J.Y.; Chen, Y.; Ma, X.J.; Wang, S.N.; Zheng, Z.Q.; Lin, M.X.; He, S. Anxiolytic-like effect of Suanzaoren-Wuweizi herb-pair and evidence for the involvement of the monoaminergic system in mice based on network pharmacology. BMC Complement. Med. Ther. 2023, 23, 7. [Google Scholar] [CrossRef] [PubMed]
  23. Zhang, D.; Zhou, Q.; Yang, X.; Zhang, Z.; Wang, D.; Hu, D.; Huang, Y.; Sheng, J.; Wang, X. Gallic Acid Can Promote Low-Density Lipoprotein Uptake in HepG2 Cells via Increasing Low-Density Lipoprotein Receptor Accumulation. Molecules 2024, 29, 1999. [Google Scholar] [CrossRef] [PubMed]
  24. Chen, L.; Tang, G.W.; Zhu, K.M.; Long, B.; Tian, X. Conformational relationship between mogroside monomers and sweet/biter taste receptors based on molecular docking and electronic tongue sensory analysis. Sci. Technol. Food Ind. 2024, 1–16. [Google Scholar] [CrossRef]
  25. Li, R.; Zhao, J.W.; Ning, T.B.; Yao, J.C.; Liang, H.B. Mechanism of Shanhuajing Granules on reliving visual fatigue based on network pharmacology and molecular docking method. Chin. Tradit. Herb. Drugs 2021, 52, 4921–4930. [Google Scholar]
  26. Volkamer, A.; Kuhn, D.; Grombacher, T.; Rippmann, F.; Rarey, M. Combining global and local measures for structure-based druggability predictions. J. Chem. Inf. Model. 2012, 52, 360–372. [Google Scholar] [CrossRef] [PubMed]
  27. Wang, Y.; Yuan, F.J.; Zhang, M.; Yu, L.; Liu, W.Y.; Wu, H.G.; Gao, J.W.; Wang, T.Y. Acetylcholinesterase Inhibition Effect of Flavonoids from Flemigia philippinensis. Sci. Technol. Food Ind. 2021, 42, 118–124. [Google Scholar]
  28. Yan, X.M.; Peng, Q.; Xu, Z.G.; Zhou, Y.; Zhao, Z.X.; Liao, Q.F.; Chen, F.L.; Zhang, L. Establishment of an HPLC-DAD Fingerprint Profile for Flemingia philippinensis. Chin. Tradit. Pat. Med. 2020, 42, 1366–1371. [Google Scholar]
  29. Li, H. Studies on the Constituents and Quality Control of Flemingia philippinensis Merr et Rolfe. Doctor Thesis, China Union Medical University, Beijing, China, 2009. [Google Scholar]
  30. Sun, F.; Li, Q.; Xu, J. Chemical Composition of Roots Flemingia philippinensis and Their Inhibitory Kinetics on Aromatase. Chem. Biodivers. 2017, 14, e1600193. [Google Scholar] [CrossRef] [PubMed]
  31. Wang, Y.; Curtis-Long, M.J.; Lee, B.W.; Yuk, H.J.; Kim, D.W.; Tan, X.F.; Park, K.H. Inhibition of tyrosinase activity by polyphenol compounds from Flemingia philippinensis roots. Bioorg. Med. Chem. 2014, 22, 1115–1120. [Google Scholar] [PubMed]
  32. Alfaro, S.; Acuña, V.; Ceriani, R.; Cavieres, M.F.; Weinstein-Oppenheimer, C.R.; Campos-Estrada, C. Involvement of Inflammation and Its Resolution in Disease and Therapeutics. Int. J. Mol. Sci. 2022, 23, 10719. [Google Scholar] [CrossRef]
  33. Netea, M.G.; Balkwill, F.; Chonchol, M.; Cominelli, F.; Donath, M.Y.; Giamarellos-Bourboulis, E.J.; Golenbock, D.; Gresnigt, M.S.; Heneka, M.T.; Hoffman, H.M.; et al. A guiding map for inflammation. Nat. Immunol. 2017, 18, 826–831. [Google Scholar] [CrossRef] [PubMed]
  34. Li, Y.C.; Pan, Z.Q.; Xiao, M.G.; Zhang, Y.Y. Advances in research on small intestinal injuries caused by nonsteroidal anti-inflammatory drugs and its prevention and treatment. J. China Pharm. Univ. 2023, 54, 150–158. [Google Scholar]
  35. Qian, Y.N.; Sun, L.Y.; Zhang, S. The role and mechanism of intestinal flora in non-steroidal anti-inflammatory drug enteropathy. Chin. J. Microecol. 2022, 34, 608–612. [Google Scholar]
  36. Radu, A.F.; Negru, P.A.; Radu, A.; Tarce, A.G.; Bungau, S.G.; Bogdan, M.A.; Tit, D.M.; Uivaraseanu, B. Simulation-Based Research on Phytoconstituents of Embelia ribes Targeting Proteins with Pathophysiological Implications in Rheumatoid Arthritis. Life 2023, 13, 1467. [Google Scholar] [CrossRef] [PubMed]
  37. Poulsen, N.B.; Lambert, M.N.T.; Jeppesen, P.B. The Effect of Plant Derived Bioactive Compounds on Inflammation: A Systematic Review and Meta-Analysis. Mol. Nutr. Food Res. 2020, 64, e2000473. [Google Scholar] [CrossRef] [PubMed]
  38. Ding, M.; Bao, Y.; Liang, H.; Zhang, X.; Li, B.; Yang, R.; Zeng, N. Potential mechanisms of formononetin against inflammation and oxidative stress: A review. Front. Pharmacol. 2024, 15, 1368765. [Google Scholar] [CrossRef] [PubMed]
  39. Qin, Q.X.; He, L.H.; Wei, M.; He, H.; Ma, L.H.; Pang, T.; Zhou, L. Mechanism of Flemiphilippinin D Regulating Inflammatory Response in CIA Rats Through TLR2/MyD88/NF-κB Signaling Pathway. Chin. J. Exp. Tradit. Med. Formulae 2023, 29, 134–141. [Google Scholar]
  40. Yousuf, M.; Shamsi, A.; Khan, S.; Khan, P.; Shahwan, M.; Elasbali, A.M.; Haque, Q.M.R.; Hassan, M.I. Naringenin as a potential inhibitor of human cyclin-dependent kinase 6: Molecular and structural insights into anti-cancer therapeutics. Int. J. Biol. Macromol. 2022, 213, 944–954. [Google Scholar] [CrossRef] [PubMed]
  41. Yadav, B.; Vishwakarma, V.; Kumar, S.; Aggarwal, N.K.; Gupta, R.; Yadav, A. Ameliorative role of naringenin against lead-induced genetic damage and oxidative stress in cultured human lymphocytes. J. Biochem. Mol. Toxicol. 2022, 36, e23036. [Google Scholar] [CrossRef] [PubMed]
  42. Sanson, C.; Boukaiba, R.; Houtmann, S.; Maizières, M.A.; Fouconnier, S.; Partiseti, M.; Bohme, G.A. The grapefruit polyphenol naringenin inhibits multiple cardiac ion channels. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2022, 395, 735–740. [Google Scholar] [CrossRef] [PubMed]
  43. Yusuf, M.A.; Singh, B.N.; Sudheer, S.; Kharwar, R.N.; Siddiqui, S.; Abdel-Azeem, A.M.; Fernandes Fraceto, L.; Dashora, K.; Gupta, V.K. Chrysophanol: A Natural Anthraquinone with Multifaceted Biotherapeutic Potential. Biomolecules 2019, 9, 68. [Google Scholar] [CrossRef] [PubMed]
  44. Liu, F.C.; Wang, C.C.; Lu, J.W.; Lee, C.H.; Chen, S.C.; Ho, Y.J.; Peng, Y.J. Chondroprotective Effects of Genistein against Osteoarthritis Induced Joint Inflammation. Nutrients 2019, 11, 1180. [Google Scholar] [CrossRef] [PubMed]
  45. Oh, Y.; Hwang, H.J.; Yang, H.; Kim, J.H.; Park, J.H.Y.; Kim, J.E.; Lee, K.W. Orobol, A Derivative of Genistein, Inhibits Heat-Killed Propionibacterium acnes-Induced Inflammation in HaCaT Keratinocytes. J. Microbiol. Biotechnol. 2020, 30, 1379–1386. [Google Scholar] [CrossRef]
  46. Wu, C.; Ba, Q.; Lu, D.; Li, W.; Salovska, B.; Hou, P.; Mueller, T.; Rosenberger, G.; Gao, E.; Di, Y.; et al. Global and Site-Specific Effect of Phosphorylation on Protein Turnover. Dev. Cell 2021, 56, 111–124.e6. [Google Scholar] [CrossRef] [PubMed]
  47. Gong, T.; Jiang, W.; Zhou, R. Control of Inflammasome Activation by Phosphorylation. Trends Biochem. Sci. 2018, 43, 685–699. [Google Scholar] [CrossRef] [PubMed]
  48. Oostindie, S.C.; Lazar, G.A.; Schuurman, J.; Parren, P. Avidity in antibody effector functions and biotherapeutic drug design. Nature reviews. Drug Discov. 2022, 21, 715–735. [Google Scholar] [CrossRef] [PubMed]
  49. Tu, H.; Xiong, W.; Zhang, J.; Zhao, X.; Lin, X. Tyrosine phosphorylation regulates RIPK1 activity to limit cell death and inflammation. Nat. Commun. 2022, 13, 6603. [Google Scholar] [CrossRef] [PubMed]
  50. Hu, D.D.; Chen, H.L.; Lou, L.M.; Zhang, H.; Yang, G.L. SKA3 promotes lung adenocarcinoma metastasis through the EGFR-PI3K-Akt axis. Biosci. Rep. 2020, 40, BSR20194335. [Google Scholar] [CrossRef]
  51. Venkatachalam, K.; Mummidi, S.; Cortez, D.M.; Prabhu, S.D.; Valente, A.J.; Chandrasekar, B. Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts. Am. J. Physiol. Heart Circ. Physiol. 2008, 294, H2078–H2087. [Google Scholar] [CrossRef] [PubMed]
  52. Wenzel, U.O.; Bode, M.; Kurts, C.; Ehmke, H. Salt, inflammation, IL-17 and hypertension. Br. J. Pharmacol. 2019, 176, 1853–1863. [Google Scholar] [CrossRef] [PubMed]
  53. Li, X.; Dong, L.L.; Guo, T.; Zhang, L.T. Natural Products Treat Atopic Dermatitis via NF-κB Signaling Pathway: A Review. Chin. J. Exp. Tradit. Med. Formulae 2024, 30, 271–280. [Google Scholar]
  54. Shi, Z.M.; Han, Y.W.; Han, X.H.; Zhang, K.; Chang, Y.N.; Hu, Z.M.; Qi, H.X.; Ting, C.; Zhen, Z.; Hong, W. Upstream regulators and downstream effectors of NF-κB in Alzheimer’s disease. J. Neurol. Sci. 2016, 366, 127–134. [Google Scholar] [CrossRef] [PubMed]
  55. Xin, Y.; Zhao, L.; Peng, R. HIF-1 signaling: An emerging mechanism for mitochondrial dynamics. J. Physiol. Biochem. 2023, 79, 489–500. [Google Scholar] [CrossRef] [PubMed]
  56. Kim, H.Y.; Kim, Y.H.; Nam, B.H.; Kong, H.J.; Kim, H.H.; Kim, Y.J.; An, W.G.; Cheong, J. HIF-1alpha expression in response to lipopolysaccaride mediates induction of hepatic inflammatory cytokine TNFalpha. Exp. Cell Res. 2007, 313, 1866–1876. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The research flow chart.
Figure 1. The research flow chart.
Nutrients 16 01850 g001
Figure 2. Intersection targets of active ingredients and inflammation in Flemingia Philippinensis extract.
Figure 2. Intersection targets of active ingredients and inflammation in Flemingia Philippinensis extract.
Nutrients 16 01850 g002
Figure 3. (A) PPI network diagram derived from the STRING database; (B) diagram of core target construction using Cytoscape software. In Figure (B), nodes represent proteins, edges represent connections between proteins, and the size and color of nodes indicate the importance of each node within the entire protein interaction network.
Figure 3. (A) PPI network diagram derived from the STRING database; (B) diagram of core target construction using Cytoscape software. In Figure (B), nodes represent proteins, edges represent connections between proteins, and the size and color of nodes indicate the importance of each node within the entire protein interaction network.
Nutrients 16 01850 g003
Figure 4. The target network of Flemingia philippinensis–active ingredients improving core targets of inflammation. In the diagram, rhomboids represent the active ingredients of Flemingia philippinensis that improve inflammation, and circles represent the core targets for inflammation improvement.
Figure 4. The target network of Flemingia philippinensis–active ingredients improving core targets of inflammation. In the diagram, rhomboids represent the active ingredients of Flemingia philippinensis that improve inflammation, and circles represent the core targets for inflammation improvement.
Nutrients 16 01850 g004
Figure 5. GO functional enrichment analysis (A1C1) and core anti-inflammatory targets (A2C2).
Figure 5. GO functional enrichment analysis (A1C1) and core anti-inflammatory targets (A2C2).
Nutrients 16 01850 g005
Figure 6. KEGG signaling pathway enrichment analysis of potential targets for anti-inflammatory improvement. The Sankey plot on the left represents the core targets included in each pathway, and the conventional bubble plot is on the right, where the bubble size indicates the number of potential targets to which the pathway belongs, and the bubble color indicates the p-value.
Figure 6. KEGG signaling pathway enrichment analysis of potential targets for anti-inflammatory improvement. The Sankey plot on the left represents the core targets included in each pathway, and the conventional bubble plot is on the right, where the bubble size indicates the number of potential targets to which the pathway belongs, and the bubble color indicates the p-value.
Nutrients 16 01850 g006
Figure 7. Diagram of PI3K–AKT signaling pathway. Red nodes indicate genes associated with improved inflammation in Flemingia philippinensis.
Figure 7. Diagram of PI3K–AKT signaling pathway. Red nodes indicate genes associated with improved inflammation in Flemingia philippinensis.
Nutrients 16 01850 g007
Figure 8. Visualization of molecular docking of the active ingredient in Flemingia philippinensis (Flemichin D) with the key target. Figures (AE) respectively display the molecular docking outcomes of Flemichin D with the following proteins: AKT1 (Figure A), TNF (Figure B), BCL2 (Figure C), ALB (Figure D), and ESR1 (Figure E).
Figure 8. Visualization of molecular docking of the active ingredient in Flemingia philippinensis (Flemichin D) with the key target. Figures (AE) respectively display the molecular docking outcomes of Flemichin D with the following proteins: AKT1 (Figure A), TNF (Figure B), BCL2 (Figure C), ALB (Figure D), and ESR1 (Figure E).
Nutrients 16 01850 g008
Table 1. Information on the active ingredients of Flemingia philippinensis.
Table 1. Information on the active ingredients of Flemingia philippinensis.
NO.Molecule NameMolecular FormulaMolecular WeightGI AbsorptionNumber of Drug-like “YES”
1(2S)-LiquiritigeninC15H13O4256.25High5
2MonopalmitinC19H38O4330.50High3
32′-HydroxygenisteinC15H10O6286.24High5
4LuteolinC15H10O6286.24High5
51,8-CineoleC10H18O154.28High3
6CubenolC15H26O222.37High4
7FormononetinC16H12O4268.26High5
8OrobolC15H10O6286.24High5
9ChrysophanolC15H10O4254.24High5
10PhyscionC16H12O5284.26High5
11DihydrodaidzeinC15H12O4256.25High5
124′,7-DihydroxyflavanoneC15H10O5254.24High5
13QuercetinC15H10O7302.24High5
143′-O-MethylorobolC16H12O6300.26High5
15ElemeneC15H24204.39High4
16Diisobutyl phthalateC16H22O4278.34High5
17o-ThymolC10H14O150.24High3
18Flemiphilippinin DC25H28O6424.50High4
19Flemiphilippinin CC26H26O6406.46High4
21MedicagolC16H8O6296.23High5
21WedelolactoneC16H10O7314.25High5
22Flemichin DC25H26O6422.47High4
23GenisteinC15H10O5270.24High5
24KaempferolC15H10O6286.24High5
25LupinifolinC25H26O5406.50High4
26PrunetinC16H12O5284.26High5
27NaringeninC15H12O5272.25High5
28LupeolC30H50O426.80Low3
29Palmitic acidC16H32O2256.42High3
Table 2. Top 10 key core targets.
Table 2. Top 10 key core targets.
NO.Gene NameTarget ProteinDegreeBetweenness CentralityCloseness Centrality
1AKT1Serine/threonine-protein kinase AKT490.041 2660.962 264
2TNFTNF-alpha470.030 9420.927 273
3BCL2Apoptosis regulator Bcl-2470.028 5280.927 273
4ALBSerum albumin470.034 0650.927 273
5ESR1Estrogen receptor alpha460.031 3920.910 714
6PPARGPeroxisome proliferator-activated receptor gamma440.026 7220.879 310
7EGFREpidermal growth factor receptor erbB1440.021 4170.879 310
8PTGS2Cyclooxygenase-2420.018 7270.850 000
9SRCTyrosine-protein kinase SRC410.014 3510.836 066
10HSP90AA1Heat shock protein HSP 90-alpha400.016 7950.822 581
Table 3. Molecular docking binding energies of key targets and components (kcal/mol).
Table 3. Molecular docking binding energies of key targets and components (kcal/mol).
Key Molecular ComponentsCore TargetsAverage Binding Energy
AKT1TNFBCL2ALBESR1
Flemichin D−9.57−8.70−8.32−8.20−7.54−8.47
Naringenin−7.82−7.48−7.01−7.60−7.96−7.57
Chrysophanol−8.00−7.20−6.25−8.85−7.29−7.52
Genistein−7.60−6.67−5.78−6.74−8.03−6.96
Orobol−7.25−6.76−6.23−7.02−8.10−7.07
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhang, D.; Zhou, Q.; Zhang, Z.; Yang, X.; Man, J.; Wang, D.; Li, X. Based on Network Pharmacology and Molecular Docking, the Active Components, Targets, and Mechanisms of Flemingia philippinensis in Improving Inflammation Were Excavated. Nutrients 2024, 16, 1850. https://doi.org/10.3390/nu16121850

AMA Style

Zhang D, Zhou Q, Zhang Z, Yang X, Man J, Wang D, Li X. Based on Network Pharmacology and Molecular Docking, the Active Components, Targets, and Mechanisms of Flemingia philippinensis in Improving Inflammation Were Excavated. Nutrients. 2024; 16(12):1850. https://doi.org/10.3390/nu16121850

Chicago/Turabian Style

Zhang, Dongying, Qixing Zhou, Zhen Zhang, Xiangxuan Yang, Jiaxu Man, Dongxue Wang, and Xiaoyong Li. 2024. "Based on Network Pharmacology and Molecular Docking, the Active Components, Targets, and Mechanisms of Flemingia philippinensis in Improving Inflammation Were Excavated" Nutrients 16, no. 12: 1850. https://doi.org/10.3390/nu16121850

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop